Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

By A. Rodriguez, M. Schiffman, R. Herrero, S. Wacholder, A. Hildesheim, P. Castle, D. Solomon, R. Burk. Journal of the National Cancer Institute, 2008

597 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/b02c572ff7c2c0174f5179ffd396578cbe63395a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Mark Schiffman
2. S. de Sanjosé
3. X. Castellsagué
4. E. Burd
5. M. Stanley

In Oncology

1. S. de Sanjosé
2. X. Castellsagué
3. E. Burd

In Surgery

1. Mark Schiffman
2. M. Stanley

Citations in the corpus

• Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. (2010, background): “The detection of HPV infection in women has been found to start consistently with a peak just after the onset of sexual relations, usually from 15 years of age [20], reaching prevalences up to 80% in some populations [16], mostly at the expense of transient infections that clear rapidly [21].”
• 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. (2013, background): “However, most HPV infections are cleared, substantially reducing risk of CIN 3+ (60), so observing women to allow clearance is attractive.”
• American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. (2012, unknown): “Most (approximately 90%) HPV infections are transient, becoming undetectable within one to 2 years.(14,15) Women whose infections persist are at significant”